Ajooni Biotech Limited — Board Meeting, 30-01-2026: Outcome of Board Meeting
30-01-2026 | 12:10 pm
30-01-2026 | 12:10 pm
Ajooni Biotech's Board approved financial results for the quarter: Net Profit at ₹1.65 Cr on ₹58.75 Cr revenue. Merger discussions with Healthy Biosciences Limited have been deferred for further evaluation.
No comments yet. Be the first to comment!
